Releuko, a filgrastim biosimilar developed by Kashiv Biosciences and Amneal Pharmaceuticals, becomes the third filgrastim biosimilar to be approved by the FDA. Releuko, a filgrastim biosimilar ...
Ivo Abraham, PhD, RN, a professor with the University of Arizona Health Sciences in the Department of Pharmacy Practice, discusses the current state of the granulocyte-colony stimulating factor (G-CSF ...
The FINANCIAL — Sandoz, a Novartis company, announced on September 3 that Zarxio(TM) (filgrastim-sndz) is now available in the United States. Zarxio is the first biosimilar approved by the US Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results